Close Menu

NEW YORK (GenomeWeb) – The Cas9 enzyme is known to have certain problems with binding to off-target DNA sequences, but for the most part, it is still considered to be the gold standard CRISPR enzyme for genome editing.

However, in a new study in Molecular Cell today, researchers from the University of Texas at Austin suggested that the Cas12a enzyme — previously known as Cpf1 — is more precise than Cas9 and could lead to gene editing that's safe enough to be used in humans.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Apr
17
Sponsored by
Isoplexis

This webinar will provide an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers.